Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Stimulates the pancreas to release insulin, supporting balanced blood sugar levels and activating key metabolic functions
K.MorrisseyJ
Together, they can reduce blood pressure, improve cholesterol, and lower cardiovascular risk
These changes include: Declining estrogen levels that promote visceral fat accumulation Accelerated loss of fat-free mass Approximately 2-3% decline in resting metabolic rate per decade after age 20 Disrupted sleep patterns that further impair metabolism GLP-1 receptor agonists offer a particularly compelling approach for addressing menopause-related weight challenges by: Directly targeting the visceral adiposity that characterizes menopausal weight gain Countering metabolic slowdown through enhanced satiety signals Improving insulin sensitivity and glucose metabolism Potentially complementing hormone replacement therapy (HRT) The relationship between GLP-1RAs and HRT deserves special attention
